Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation

Journal of Experimental Medicine

Volumn 193, Issue 12, 2001, Pages 1361-1371

  Lallemand Breitenbach, Valérie ^a   Zhu, Jun ^a   Puvion, Francine ^b   Koken, Marcel ^a   Honoré, Nicole ^a   Doubeikovsky, Alexandre ^a   Duprez, Estelle ^c   Pandolfi, Pier Paolo ^d   Puvion, Edmond ^b   Freemont, Paul ^c   De Thé, Hugues ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CNRS   (France)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Arsenic; Interferon; Leukemia; Nuclear matrix; Ubiquitin

Indexed keywords

PROTEASOME; RETINOIC ACID RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS MATRIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION;

ADENOSINE TRIPHOSPHATASES; AMINO ACID MOTIFS; ANIMALS; ARSENICALS; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; CHO CELLS; CRICETINAE; ENDOPEPTIDASES; MICE; MODELS, BIOLOGICAL; MUTATION; NEOPLASM PROTEINS; NUCLEAR MATRIX; NUCLEAR PROTEINS; OXIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTORS, RETINOIC ACID; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 0035908032     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.12.1361     Document Type: Article

References (50)

1. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
2. RING for destruction?
3. PML is essential for multiple apoptotic pathways
4. Role of PML in cell growth and the retinoic acid pathway
5. PML induces a caspase-independent cell death process
6. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
7. PML is induced by oncogenic ras and promotes premature senescence
8. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
9. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors
10. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins
11. Sequestration and inhibition of daxx-mediated transcriptional repression by PML
12. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
13. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia
14. The t(15;17) translocation alters a nuclear body in a RA-reversible fashion
15. PML protein expression in hematopoietic and acute promyelocytic leukemia cells
16. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
17. Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukemia cells
18. Nuclear bodies: Multifaceted subdomains of the interchromatin space
19. Role of SUMO-1-modified PML in nuclear body formation
20. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
21. Role of promyelocytic leukemia protein (PML) in tumor supression
22. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2
23. SUMO-1 modification of IκBα inhibits NF-κB activation
24. Identification of three major sentrinization sites in PML
25. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localization
26. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
27. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
28. Regulation of Pax3 transcriptional activity by SUMO-modified PML
29. Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
30. Covalent modification of PML by the sentrin family of ubiquitin-like proteins
31. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
32. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals
33. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells
34. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins
35. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
36. Cell cycle regulation of PML modification and ND10 composition
37. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein
38. Cell type- and differentiation stage-dependent expression of PML domains in rat, detected by monoclonal antibody HIS55
39. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
40. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
41. A critical role for the proteasome activator PA28 in the HSP90-dependent protein refolding
42. RING finger proteins: Mediators of ubiquitin ligase activity
43. Interferonγ regulates accumulation of the proteasome activator PA28 and immunoproteasome at nuclear PML bodies
44. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
45. Intracellular localization of proteasomal degradation of a viral antigen
46. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
47. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
48. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins
49. The disruption of ND10 during herpes simplex virus infection correlates with the VmW110- and proteasome-dependent loss of several PML isoforms
50. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption